2nd Circ. Quashes Savient Investor’s Class Action – site.law360.com
Law360, New York (January 17, 2012, 9:15 PM ET) -- The Second Circuit on Friday backed the dismissal of a putative securities fraud class action accusing Savient Pharmaceuticals Inc. of misleading investors by holding back reports of adverse reactions to ...
Subscribe to LegalLaw247.Com Newsletter